메뉴 건너뛰기




Volumn 40, Issue 8, 2014, Pages 893-899

Contemporary controversies and perspectives in the staging and treatment of patients with lymph node metastasis from melanoma, especially with regards positive sentinel lymph node biopsy

Author keywords

Adjuvant; Lymph node; Lymphadenectomy; Melanoma; Sentinel lymph node; Staging

Indexed keywords

ALPHA INTERFERON;

EID: 84904790011     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2014.06.008     Document Type: Review
Times cited : (18)

References (82)
  • 2
    • 79151469677 scopus 로고    scopus 로고
    • The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins
    • Mocellin S., Pasquali S., Nitti D. The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins. Ann Surg 2011, 253:238-243.
    • (2011) Ann Surg , vol.253 , pp. 238-243
    • Mocellin, S.1    Pasquali, S.2    Nitti, D.3
  • 4
    • 84872614316 scopus 로고    scopus 로고
    • Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review
    • Ascierto P.A., Gogas H.J., Grob J.J., Algarra S.M., Mohr P., Hansson J., et al. Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review. Crit Rev Oncol Hematol 2013, 85:149-161.
    • (2013) Crit Rev Oncol Hematol , vol.85 , pp. 149-161
    • Ascierto, P.A.1    Gogas, H.J.2    Grob, J.J.3    Algarra, S.M.4    Mohr, P.5    Hansson, J.6
  • 7
    • 84873670582 scopus 로고    scopus 로고
    • Call for a balanced view on sentinel node biopsy for melanoma
    • Geh J.L., Healy C., Lacy K., Wain M., Attard N., Calonje E., et al. Call for a balanced view on sentinel node biopsy for melanoma. BMJ 2013, 346:f648.
    • (2013) BMJ , vol.346
    • Geh, J.L.1    Healy, C.2    Lacy, K.3    Wain, M.4    Attard, N.5    Calonje, E.6
  • 11
    • 79957970164 scopus 로고    scopus 로고
    • Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria
    • van der Ploeg A.P., van Akkooi A.C., Rutkowski P., Nowecki Z.I., Michej W., Mitra A., et al. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol 2011, 29:2206-2214.
    • (2011) J Clin Oncol , vol.29 , pp. 2206-2214
    • van der Ploeg, A.P.1    van Akkooi, A.C.2    Rutkowski, P.3    Nowecki, Z.I.4    Michej, W.5    Mitra, A.6
  • 12
    • 77952532215 scopus 로고    scopus 로고
    • Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases
    • Balch C.M., Gershenwald J.E., Soong S.J., Thompson J.F., Ding S., Byrd D.R., et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010, 28:2452-2459.
    • (2010) J Clin Oncol , vol.28 , pp. 2452-2459
    • Balch, C.M.1    Gershenwald, J.E.2    Soong, S.J.3    Thompson, J.F.4    Ding, S.5    Byrd, D.R.6
  • 13
    • 77149124228 scopus 로고    scopus 로고
    • Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis
    • Pasquali S., Mocellin S., Campana L.G., Bonandini E., Montesco M.C., Tregnaghi A., et al. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis. Cancer 2010, 116:1201-1209.
    • (2010) Cancer , vol.116 , pp. 1201-1209
    • Pasquali, S.1    Mocellin, S.2    Campana, L.G.3    Bonandini, E.4    Montesco, M.C.5    Tregnaghi, A.6
  • 14
    • 84891717162 scopus 로고    scopus 로고
    • Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden
    • Spillane A.J., Pasquali S., Haydu L.E., Thompson J.F. Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden. Ann Surg Oncol 2014, 21:292-299.
    • (2014) Ann Surg Oncol , vol.21 , pp. 292-299
    • Spillane, A.J.1    Pasquali, S.2    Haydu, L.E.3    Thompson, J.F.4
  • 15
    • 84868205047 scopus 로고    scopus 로고
    • Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma
    • Morton D.L. Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 2012, 29:699-706.
    • (2012) Clin Exp Metastasis , vol.29 , pp. 699-706
    • Morton, D.L.1
  • 16
    • 84876494846 scopus 로고    scopus 로고
    • Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey
    • Pasquali S., Spillane A.J., de Wilt J.H., McCaffery K., Rossi C.R., Quinn M.J., et al. Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey. Ann Surg Oncol. 2012, 19:4322-4329.
    • (2012) Ann Surg Oncol. , vol.19 , pp. 4322-4329
    • Pasquali, S.1    Spillane, A.J.2    de Wilt, J.H.3    McCaffery, K.4    Rossi, C.R.5    Quinn, M.J.6
  • 17
    • 79751522951 scopus 로고    scopus 로고
    • Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial
    • Giuliano A.E., Hunt K.K., Ballman K.V., Beitsch P.D., Whitworth P.W., Blumencranz P.W., et al. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011, 305:569-575.
    • (2011) JAMA , vol.305 , pp. 569-575
    • Giuliano, A.E.1    Hunt, K.K.2    Ballman, K.V.3    Beitsch, P.D.4    Whitworth, P.W.5    Blumencranz, P.W.6
  • 18
    • 84900421315 scopus 로고    scopus 로고
    • Sentinel lymph node biopsy for patients with early-stage breast cancer: american Society of Clinical Oncology clinical practice guideline update
    • Lyman G.H., Temin S., Edge S.B., Newman L.A., Turner R.R., Weaver D.L., et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: american Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2014, 32:1365-1383.
    • (2014) J Clin Oncol , vol.32 , pp. 1365-1383
    • Lyman, G.H.1    Temin, S.2    Edge, S.B.3    Newman, L.A.4    Turner, R.R.5    Weaver, D.L.6
  • 19
    • 84891627916 scopus 로고    scopus 로고
    • The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients
    • van der Ploeg A.P., van Akkooi A.C., Haydu L.E., Scolyer R.A., Murali R., Verhoef C., et al. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. Eur J Cancer 2014, 50:111-120.
    • (2014) Eur J Cancer , vol.50 , pp. 111-120
    • van der Ploeg, A.P.1    van Akkooi, A.C.2    Haydu, L.E.3    Scolyer, R.A.4    Murali, R.5    Verhoef, C.6
  • 20
    • 4344630988 scopus 로고    scopus 로고
    • The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement
    • Dewar D.J., Newell B., Green M.A., Topping A.P., Powell B.W., Cook M.G. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004, 22:3345-3349.
    • (2004) J Clin Oncol , vol.22 , pp. 3345-3349
    • Dewar, D.J.1    Newell, B.2    Green, M.A.3    Topping, A.P.4    Powell, B.W.5    Cook, M.G.6
  • 21
    • 0035371058 scopus 로고    scopus 로고
    • A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma
    • Starz H., Balda B.R., Kramer K.U., Buchels H., Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001, 91:2110-2121.
    • (2001) Cancer , vol.91 , pp. 2110-2121
    • Starz, H.1    Balda, B.R.2    Kramer, K.U.3    Buchels, H.4    Wang, H.5
  • 22
    • 52049107850 scopus 로고    scopus 로고
    • Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma
    • Gershenwald J.E., Andtbacka R.H., Prieto V.G., Johnson M.M., Diwan A.H., Lee J.E., et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 2008, 26:4296-4303.
    • (2008) J Clin Oncol , vol.26 , pp. 4296-4303
    • Gershenwald, J.E.1    Andtbacka, R.H.2    Prieto, V.G.3    Johnson, M.M.4    Diwan, A.H.5    Lee, J.E.6
  • 23
    • 0034979375 scopus 로고    scopus 로고
    • Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment
    • Cochran A.J., Morton D.L., Stern S., Lana A.M., Essner R., Wen D.R. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 2001, 14:604-608.
    • (2001) Mod Pathol , vol.14 , pp. 604-608
    • Cochran, A.J.1    Morton, D.L.2    Stern, S.3    Lana, A.M.4    Essner, R.5    Wen, D.R.6
  • 24
    • 78649456985 scopus 로고    scopus 로고
    • Non-sentinel node risk score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes
    • Murali R., Desilva C., Thompson J.F., Scolyer R.A. Non-sentinel node risk score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes. J Clin Oncol 2010, 28:4441-4449.
    • (2010) J Clin Oncol , vol.28 , pp. 4441-4449
    • Murali, R.1    Desilva, C.2    Thompson, J.F.3    Scolyer, R.A.4
  • 25
    • 84899761053 scopus 로고    scopus 로고
    • Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study
    • Pasquali S., Mocellin S., Mozzillo N., Maurichi A., Quaglino P., Borgognoni L., et al. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. J Clin Oncol 2014.
    • (2014) J Clin Oncol
    • Pasquali, S.1    Mocellin, S.2    Mozzillo, N.3    Maurichi, A.4    Quaglino, P.5    Borgognoni, L.6
  • 26
    • 84873735877 scopus 로고    scopus 로고
    • Completion lymph node dissection after a positive sentinel node: no longer a must?
    • van der Ploeg A.P., van Akkooi A.C., Verhoef C., Eggermont A.M. Completion lymph node dissection after a positive sentinel node: no longer a must?. Curr Opin Oncol 2013, 25:152-159.
    • (2013) Curr Opin Oncol , vol.25 , pp. 152-159
    • van der Ploeg, A.P.1    van Akkooi, A.C.2    Verhoef, C.3    Eggermont, A.M.4
  • 27
    • 84865112386 scopus 로고    scopus 로고
    • Australian Cancer Network Melanoma Guidelines Revision Working Party
    • Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, Wellington
    • Australian Cancer Network Melanoma Guidelines Revision Working Party Clinical practice guidelines for the management of melanoma in Australia and New Zealand 2008, Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, Wellington.
    • (2008) Clinical practice guidelines for the management of melanoma in Australia and New Zealand
  • 28
    • 85081463830 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Melanoma. [accessed on 1st June 2014].
    • National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Melanoma. www.nccn.org 2014 [accessed on 1st June 2014].
    • (2014)
  • 29
    • 84893933188 scopus 로고    scopus 로고
    • Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma
    • Gyorki D.E., Boyle J.O., Ganly I., Morris L., Shaha A.R., Singh B., et al. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma. Eur J Surg Oncol 2014, 40:305-310.
    • (2014) Eur J Surg Oncol , vol.40 , pp. 305-310
    • Gyorki, D.E.1    Boyle, J.O.2    Ganly, I.3    Morris, L.4    Shaha, A.R.5    Singh, B.6
  • 30
    • 84860422478 scopus 로고    scopus 로고
    • Is a level III dissection necessary for a positive sentinel lymph node in melanoma?
    • Namm J.P., Chang A.E., Cimmino V.M., Rees R.S., Johnson T.M., Sabel M.S. Is a level III dissection necessary for a positive sentinel lymph node in melanoma?. J Surg Oncol 2012, 105:225-228.
    • (2012) J Surg Oncol , vol.105 , pp. 225-228
    • Namm, J.P.1    Chang, A.E.2    Cimmino, V.M.3    Rees, R.S.4    Johnson, T.M.5    Sabel, M.S.6
  • 31
    • 84878247233 scopus 로고    scopus 로고
    • How often do level III nodes bear melanoma metastases and does it affect patient outcomes?
    • Nessim C., Law C., McConnell Y., Shachar S., McKinnon G., Wright F. How often do level III nodes bear melanoma metastases and does it affect patient outcomes?. Ann Surg Oncol 2013, 20:2056-2064.
    • (2013) Ann Surg Oncol , vol.20 , pp. 2056-2064
    • Nessim, C.1    Law, C.2    McConnell, Y.3    Shachar, S.4    McKinnon, G.5    Wright, F.6
  • 32
    • 80052757930 scopus 로고    scopus 로고
    • Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population
    • Spillane A.J., Haydu L., McMillan W., Stretch J.R., Thompson J.F. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population. Ann Surg Oncol. 2011, 18:2521-2528.
    • (2011) Ann Surg Oncol. , vol.18 , pp. 2521-2528
    • Spillane, A.J.1    Haydu, L.2    McMillan, W.3    Stretch, J.R.4    Thompson, J.F.5
  • 33
    • 63449105286 scopus 로고    scopus 로고
    • Proposed quality standards for regional lymph node dissections in patients with1 melanoma
    • Spillane A.J., Cheung B.L., Stretch J.R., Scolyer R.A., Shannon K.F., Quinn M.J., et al. Proposed quality standards for regional lymph node dissections in patients with1 melanoma. Ann Surg 2009, 249:473-480.
    • (2009) Ann Surg , vol.249 , pp. 473-480
    • Spillane, A.J.1    Cheung, B.L.2    Stretch, J.R.3    Scolyer, R.A.4    Shannon, K.F.5    Quinn, M.J.6
  • 34
    • 85081463373 scopus 로고    scopus 로고
    • ANZMTG 01.12 Inguinal or Ilio-inguinal Lymphadenectomy for patients with metastatic melanoma to groin lymph nodes and no evidence of pelvic disease on PET/CT Scan - A randomised phase III trial (EAGLE FM)
    • ANZMTG 01.12 Inguinal or Ilio-inguinal Lymphadenectomy for patients with metastatic melanoma to groin lymph nodes and no evidence of pelvic disease on PET/CT Scan - A randomised phase III trial (EAGLE FM) 2013.
    • (2013)
  • 35
    • 80052778929 scopus 로고    scopus 로고
    • Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality
    • Wong S.L. Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality. Jama 2011, 306:1139-1141.
    • (2011) Jama , vol.306 , pp. 1139-1141
    • Wong, S.L.1
  • 36
    • 84904675632 scopus 로고    scopus 로고
    • The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis
    • Rossi C.R., Mozzillo N., Maurichi A., Pasquali S., Quaglino P., Borgognoni Lorenzo, et al. The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis. Ann Oncol 2014, 25:240-246.
    • (2014) Ann Oncol , vol.25 , pp. 240-246
    • Rossi, C.R.1    Mozzillo, N.2    Maurichi, A.3    Pasquali, S.4    Quaglino, P.5    Borgognoni, L.6
  • 38
    • 84897018318 scopus 로고    scopus 로고
    • Phase II pilot study of intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence
    • Payne M.J., Argyropoulou K., Lorigan P., McAleer J.J., Farrugia D., Davidson N., et al. Phase II pilot study of intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence. J Clin Oncol 2014, 32:185-190.
    • (2014) J Clin Oncol , vol.32 , pp. 185-190
    • Payne, M.J.1    Argyropoulou, K.2    Lorigan, P.3    McAleer, J.J.4    Farrugia, D.5    Davidson, N.6
  • 39
    • 33748068119 scopus 로고    scopus 로고
    • The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis
    • Mocellin S., Hoon D., Ambrosi A., Nitti D., Rossi C.R. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res 2006, 12:4605-4613.
    • (2006) Clin Cancer Res , vol.12 , pp. 4605-4613
    • Mocellin, S.1    Hoon, D.2    Ambrosi, A.3    Nitti, D.4    Rossi, C.R.5
  • 40
    • 70450240907 scopus 로고    scopus 로고
    • Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)
    • Fusi A., Collette S., Busse A., Suciu S., Rietz A., Santinami M., et al. Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study). Eur J Cancer 2009, 45:3189-3197.
    • (2009) Eur J Cancer , vol.45 , pp. 3189-3197
    • Fusi, A.1    Collette, S.2    Busse, A.3    Suciu, S.4    Rietz, A.5    Santinami, M.6
  • 41
    • 84655168007 scopus 로고    scopus 로고
    • Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
    • Eggermont A.M., Suciu S., Testori A., Kruit W.H., Marsden J., Punt C.J., et al. Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer 2012, 48:218-225.
    • (2012) Eur J Cancer , vol.48 , pp. 218-225
    • Eggermont, A.M.1    Suciu, S.2    Testori, A.3    Kruit, W.H.4    Marsden, J.5    Punt, C.J.6
  • 42
    • 84869212118 scopus 로고    scopus 로고
    • Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma
    • Eggermont A.M., Suciu S., Testori A., Santinami M., Kruit W.H., Marsden J., et al. Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. J Clin Oncol 2012, 30:3810-3818.
    • (2012) J Clin Oncol , vol.30 , pp. 3810-3818
    • Eggermont, A.M.1    Suciu, S.2    Testori, A.3    Santinami, M.4    Kruit, W.H.5    Marsden, J.6
  • 43
    • 77956196304 scopus 로고    scopus 로고
    • Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma
    • discussion 5-6
    • McMasters K.M., Edwards M.J., Ross M.I., Reintgen D.S., Martin R.C., Urist M.M., et al. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg 2010, 252:460-465. discussion 5-6.
    • (2010) Ann Surg , vol.252 , pp. 460-465
    • McMasters, K.M.1    Edwards, M.J.2    Ross, M.I.3    Reintgen, D.S.4    Martin, R.C.5    Urist, M.M.6
  • 44
    • 84867313947 scopus 로고    scopus 로고
    • IFN-alpha in the treatment of melanoma
    • Tarhini A.A., Gogas H., Kirkwood J.M. IFN-alpha in the treatment of melanoma. J Immunol 2012, 189:3789-3793.
    • (2012) J Immunol , vol.189 , pp. 3789-3793
    • Tarhini, A.A.1    Gogas, H.2    Kirkwood, J.M.3
  • 45
    • 84863393623 scopus 로고    scopus 로고
    • Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma
    • Wilmott J.S., Long G.V., Howle J.R., Haydu L.E., Sharma R.N., Thompson J.F., et al. Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma. Clin Cancer Res 2012, 18:1386-1394.
    • (2012) Clin Cancer Res , vol.18 , pp. 1386-1394
    • Wilmott, J.S.1    Long, G.V.2    Howle, J.R.3    Haydu, L.E.4    Sharma, R.N.5    Thompson, J.F.6
  • 46
  • 47
    • 84864052441 scopus 로고    scopus 로고
    • Management of immune-related adverse events and kinetics of response with ipilimumab
    • Weber J.S., Kahler K.C., Hauschild A. Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol 2012, 30:2691-2697.
    • (2012) J Clin Oncol , vol.30 , pp. 2691-2697
    • Weber, J.S.1    Kahler, K.C.2    Hauschild, A.3
  • 48
    • 84861574744 scopus 로고    scopus 로고
    • Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
    • Burmeister B.H., Henderson M.A., Ainslie J., Fisher R., Di Iulio J., Smithers B.M., et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol 2012, 13:589-597.
    • (2012) Lancet Oncol , vol.13 , pp. 589-597
    • Burmeister, B.H.1    Henderson, M.A.2    Ainslie, J.3    Fisher, R.4    Di Iulio, J.5    Smithers, B.M.6
  • 49
    • 79952453763 scopus 로고    scopus 로고
    • Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032
    • Sambade M.J., Peters E.C., Thomas N.E., Kaufmann W.K., Kimple R.J., Shields J.M. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother Oncol 2011, 98:394-399.
    • (2011) Radiother Oncol , vol.98 , pp. 394-399
    • Sambade, M.J.1    Peters, E.C.2    Thomas, N.E.3    Kaufmann, W.K.4    Kimple, R.J.5    Shields, J.M.6
  • 51
    • 80052016114 scopus 로고    scopus 로고
    • Neoadjuvant therapy for high-risk bulky regional melanoma
    • Tarhini A.A., Pahuja S., Kirkwood J.M. Neoadjuvant therapy for high-risk bulky regional melanoma. J Surg Oncol 2011, 104:386-390.
    • (2011) J Surg Oncol , vol.104 , pp. 386-390
    • Tarhini, A.A.1    Pahuja, S.2    Kirkwood, J.M.3
  • 52
    • 73949134034 scopus 로고    scopus 로고
    • Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma
    • Sanki A., Uren R.F., Moncrieff M., Tran K.L., Scolyer R.A., Lin H.Y., et al. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol 2009, 27:5614-5619.
    • (2009) J Clin Oncol , vol.27 , pp. 5614-5619
    • Sanki, A.1    Uren, R.F.2    Moncrieff, M.3    Tran, K.L.4    Scolyer, R.A.5    Lin, H.Y.6
  • 53
    • 77149167615 scopus 로고    scopus 로고
    • Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?
    • Voit C.A., van Akkooi A.C., Schafer-Hesterberg G., Schoengen A., Schmitz P.I., Sterry W., et al. Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?. J Clin Oncol 2009, 27:4994-5000.
    • (2009) J Clin Oncol , vol.27 , pp. 4994-5000
    • Voit, C.A.1    van Akkooi, A.C.2    Schafer-Hesterberg, G.3    Schoengen, A.4    Schmitz, P.I.5    Sterry, W.6
  • 54
    • 84881478947 scopus 로고    scopus 로고
    • Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup
    • Niebling M.G., Bastiaannet E., Hoekstra O.S., Bonenkamp J.J., Koelemij R., Hoekstra H.J. Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup. Ann Surg Oncol 2013, 20:3098-3105.
    • (2013) Ann Surg Oncol , vol.20 , pp. 3098-3105
    • Niebling, M.G.1    Bastiaannet, E.2    Hoekstra, O.S.3    Bonenkamp, J.J.4    Koelemij, R.5    Hoekstra, H.J.6
  • 55
    • 84863403429 scopus 로고    scopus 로고
    • Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma
    • Bastiaannet E., Uyl-de Groot C.A., Brouwers A.H., van der Jagt E.J., Hoekstra O.S., Oyen W., et al. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann Surg 2012, 255:771-776.
    • (2012) Ann Surg , vol.255 , pp. 771-776
    • Bastiaannet, E.1    Uyl-de Groot, C.A.2    Brouwers, A.H.3    van der Jagt, E.J.4    Hoekstra, O.S.5    Oyen, W.6
  • 56
    • 84896987510 scopus 로고    scopus 로고
    • Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma
    • Baker J.J., Meyers M.O., Frank J., Amos K.D., Stitzenberg K.B., Ollila D.W. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma. Am J Surg 2014, 207:549-554.
    • (2014) Am J Surg , vol.207 , pp. 549-554
    • Baker, J.J.1    Meyers, M.O.2    Frank, J.3    Amos, K.D.4    Stitzenberg, K.B.5    Ollila, D.W.6
  • 58
  • 59
    • 84856230673 scopus 로고    scopus 로고
    • Treatment influencing down-staging in EORTC melanoma group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study
    • Riber-Hansen R., Hastrup N., Clemmensen O., Behrendt N., Klausen S., Ramsing M., et al. Treatment influencing down-staging in EORTC melanoma group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study. Eur J Cancer 2012, 48:347-352.
    • (2012) Eur J Cancer , vol.48 , pp. 347-352
    • Riber-Hansen, R.1    Hastrup, N.2    Clemmensen, O.3    Behrendt, N.4    Klausen, S.5    Ramsing, M.6
  • 60
    • 70350516030 scopus 로고    scopus 로고
    • Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma
    • Murali R., Cochran A.J., Cook M.G., Hillman J.D., Karim R.Z., Moncrieff M., et al. Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer 2009, 115:5026-5037.
    • (2009) Cancer , vol.115 , pp. 5026-5037
    • Murali, R.1    Cochran, A.J.2    Cook, M.G.3    Hillman, J.D.4    Karim, R.Z.5    Moncrieff, M.6
  • 61
    • 84862492507 scopus 로고    scopus 로고
    • Sentinel lymph nodes containing very small (<0.1mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative
    • Murali R., DeSilva C., McCarthy S.W., Thompson J.F., Scolyer R.A. Sentinel lymph nodes containing very small (<0.1mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative. Ann Surg Oncol 2012, 19:1089-1099.
    • (2012) Ann Surg Oncol , vol.19 , pp. 1089-1099
    • Murali, R.1    DeSilva, C.2    McCarthy, S.W.3    Thompson, J.F.4    Scolyer, R.A.5
  • 62
    • 77954953195 scopus 로고    scopus 로고
    • Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model
    • Wiener M., Acland K.M., Shaw H.M., Soong S.J., Lin H.Y., Chen D.T., et al. Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model. Ann Surg Oncol 2010, 17:1995-2005.
    • (2010) Ann Surg Oncol , vol.17 , pp. 1995-2005
    • Wiener, M.1    Acland, K.M.2    Shaw, H.M.3    Soong, S.J.4    Lin, H.Y.5    Chen, D.T.6
  • 64
    • 84892368130 scopus 로고    scopus 로고
    • Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma
    • Grotz T.E., Huebner M., Pockaj B.A., Perkins S., Jakub J.W. Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma. Ann Surg Oncol. 2013, 20:4370-4377.
    • (2013) Ann Surg Oncol. , vol.20 , pp. 4370-4377
    • Grotz, T.E.1    Huebner, M.2    Pockaj, B.A.3    Perkins, S.4    Jakub, J.W.5
  • 65
    • 84885577769 scopus 로고    scopus 로고
    • Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome
    • Hughes M.C., Wright A., Barbour A., Thomas J., Smithers B.M., Green A.C., et al. Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome. Int J Cancer 2013, 133:3000-3007.
    • (2013) Int J Cancer , vol.133 , pp. 3000-3007
    • Hughes, M.C.1    Wright, A.2    Barbour, A.3    Thomas, J.4    Smithers, B.M.5    Green, A.C.6
  • 66
    • 78751629245 scopus 로고    scopus 로고
    • Lymph node ratio provides prognostic information in addition to american joint committee on cancer N stage in patients with melanoma, even if quality of surgery is standardized
    • Spillane A.J., Cheung B.L., Winstanley J., Thompson J.F. Lymph node ratio provides prognostic information in addition to american joint committee on cancer N stage in patients with melanoma, even if quality of surgery is standardized. Ann Surg 2011, 253:109-115.
    • (2011) Ann Surg , vol.253 , pp. 109-115
    • Spillane, A.J.1    Cheung, B.L.2    Winstanley, J.3    Thompson, J.F.4
  • 67
    • 36148966515 scopus 로고    scopus 로고
    • Hospital lymph node examination rates and survival after resection for colon cancer
    • Wong S.L., Ji H., Hollenbeck B.K., Morris A.M., Baser O., Birkmeyer J.D. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 2007, 298:2149-2154.
    • (2007) JAMA , vol.298 , pp. 2149-2154
    • Wong, S.L.1    Ji, H.2    Hollenbeck, B.K.3    Morris, A.M.4    Baser, O.5    Birkmeyer, J.D.6
  • 69
    • 80052034187 scopus 로고    scopus 로고
    • Prognostic molecular biomarkers for cutaneous malignant melanoma
    • Tanaka R., Koyanagi K., Narita N., Kuo C., Hoon D.S. Prognostic molecular biomarkers for cutaneous malignant melanoma. J Surg Oncol 2011, 104:438-446.
    • (2011) J Surg Oncol , vol.104 , pp. 438-446
    • Tanaka, R.1    Koyanagi, K.2    Narita, N.3    Kuo, C.4    Hoon, D.S.5
  • 70
    • 78751622090 scopus 로고    scopus 로고
    • Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients
    • Nicholl M.B., Elashoff D., Takeuchi H., Morton D.L., Hoon D.S. Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients. Ann Surg 2011, 253:116-122.
    • (2011) Ann Surg , vol.253 , pp. 116-122
    • Nicholl, M.B.1    Elashoff, D.2    Takeuchi, H.3    Morton, D.L.4    Hoon, D.S.5
  • 71
    • 34248212172 scopus 로고    scopus 로고
    • Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis
    • Mocellin S., Hoon D.S., Pilati P., Rossi C.R., Nitti D. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol 2007, 25:1588-1595.
    • (2007) J Clin Oncol , vol.25 , pp. 1588-1595
    • Mocellin, S.1    Hoon, D.S.2    Pilati, P.3    Rossi, C.R.4    Nitti, D.5
  • 72
    • 33749054227 scopus 로고    scopus 로고
    • Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival
    • Cascinelli N., Bombardieri E., Bufalino R., Camerini T., Carbone A., Clemente C., et al. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. J Clin Oncol 2006, 24:4464-4471.
    • (2006) J Clin Oncol , vol.24 , pp. 4464-4471
    • Cascinelli, N.1    Bombardieri, E.2    Bufalino, R.3    Camerini, T.4    Carbone, A.5    Clemente, C.6
  • 74
    • 84864059882 scopus 로고    scopus 로고
    • Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma
    • Azimi F., Scolyer R.A., Rumcheva P., Moncrieff M., Murali R., McCarthy S.W., et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol 2012, 30:2678-2683.
    • (2012) J Clin Oncol , vol.30 , pp. 2678-2683
    • Azimi, F.1    Scolyer, R.A.2    Rumcheva, P.3    Moncrieff, M.4    Murali, R.5    McCarthy, S.W.6
  • 75
    • 84859433376 scopus 로고    scopus 로고
    • Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
    • Storr S.J., Safuan S., Mitra A., Elliott F., Walker C., Vasko M.J., et al. Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma. Mod Pathol 2012, 25:493-504.
    • (2012) Mod Pathol , vol.25 , pp. 493-504
    • Storr, S.J.1    Safuan, S.2    Mitra, A.3    Elliott, F.4    Walker, C.5    Vasko, M.J.6
  • 77
    • 0038243830 scopus 로고    scopus 로고
    • Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival
    • Dadras S.S., Paul T., Bertoncini J., Brown L.F., Muzikansky A., Jackson D.G., et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003, 162:1951-1960.
    • (2003) Am J Pathol , vol.162 , pp. 1951-1960
    • Dadras, S.S.1    Paul, T.2    Bertoncini, J.3    Brown, L.F.4    Muzikansky, A.5    Jackson, D.G.6
  • 79
    • 33745077057 scopus 로고    scopus 로고
    • Immune responses in the draining lymph nodes against cancer: implications for immunotherapy
    • Shu S., Cochran A.J., Huang R.R., Morton D.L., Maecker H.T. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy. Cancer Metastasis Rev 2006, 25:233-242.
    • (2006) Cancer Metastasis Rev , vol.25 , pp. 233-242
    • Shu, S.1    Cochran, A.J.2    Huang, R.R.3    Morton, D.L.4    Maecker, H.T.5
  • 80
    • 84863480813 scopus 로고    scopus 로고
    • Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node
    • Ma M.W., Medicherla R.C., Qian M., Vega-Saenz de Miera E., Friedman E.B., Berman R.S., et al. Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node. Mod Pathol 2012, 25:1000-1010.
    • (2012) Mod Pathol , vol.25 , pp. 1000-1010
    • Ma, M.W.1    Medicherla, R.C.2    Qian, M.3    Vega-Saenz de Miera, E.4    Friedman, E.B.5    Berman, R.S.6
  • 81
    • 84873809917 scopus 로고    scopus 로고
    • Prognostic value of BRAF (V600) mutations in melanoma patients after resection of metastatic lymph nodes
    • Moreau S., Saiag P., Aegerter P., Bosset D., Longvert C., Helias-Rodzewicz Z., et al. Prognostic value of BRAF (V600) mutations in melanoma patients after resection of metastatic lymph nodes. Ann Surg Oncol 2012, 19:4314-4321.
    • (2012) Ann Surg Oncol , vol.19 , pp. 4314-4321
    • Moreau, S.1    Saiag, P.2    Aegerter, P.3    Bosset, D.4    Longvert, C.5    Helias-Rodzewicz, Z.6
  • 82
    • 84872595484 scopus 로고    scopus 로고
    • BRAF mutation, NRAS mutation, and the Absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma
    • Mann G.J., Pupo G.M., Campain A.E., Carter C.D., Schramm S.J., Pianova S., et al. BRAF mutation, NRAS mutation, and the Absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. J Invest Dermatol 2013, 133:509-517.
    • (2013) J Invest Dermatol , vol.133 , pp. 509-517
    • Mann, G.J.1    Pupo, G.M.2    Campain, A.E.3    Carter, C.D.4    Schramm, S.J.5    Pianova, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.